Supplement: Living with Schizophrenia

Living with Schizophrenia By Anne Harding Hallucinations are just the beginning: Negative symptoms and lowered expectations make for a tough day-to-day struggle. ARTICLE EXTRAS The Disease Robin Cunningham Marianne Emanuel A Very Expensive Disease Schizophrenia in Childhood Lina Sorenson, 49, knows when it's time for her to start taking her Stelazine for her schizophrenia. It begins with thinking she can control other people's thoughts a

Written byAnne Harding
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The Disease

Robin Cunningham

Marianne Emanuel

A Very Expensive Disease

Schizophrenia in Childhood

Lina Sorenson, 49, knows when it's time for her to start taking her Stelazine for her schizophrenia. It begins with thinking she can control other people's thoughts and read minds, which she admits can be "fun." But these thoughts quickly spiral out of control, with voices urging her to step onto the third rail of the subway if she doesn't want to lose her powers. "I have to be vigilant because I know that fun times can turn into a horror show at any time," says Sorenson, a former opera singer and musical theater actress. Staying on medication consistently is recommended for most individuals with schizophrenia, but for some patients, taking them only when symptoms threaten is appropriate, some clinicians say. Sorenson says she stays in "very close touch" with her doctor.

When most people imagine someone ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies